A press release from the European Society of Medical Oncology (ESMO) discusses the importance and need for "ethnically diverse prostate cancer genomics data and accessible genetic testing." According to Dr. Rodrigo Dienstmann, an oncologist with joint appointments at the Grupo Oncoclinicas in Sao Paulo Brazil as well as the Vall d'Hebron Institute of Oncology in Barcelona, Spain, predisposition to prostate cancer does vary across ethnicities, particularly in men of African and Caribbean descent, who are at increased risk: "such race-related differences can condition the behaviour of the disease and its treatment, yet our current knowledge of prostate cancer genomics is largely limited to data from Europe and the USA, in which Asian and other non-Caucasian ethnicities are scarcely represented."
To learn more about this press release, click here.
No comments:
Post a Comment